U.S. maternal mortality fell to 17.9 per 100,000 live births in 2024, the lowest rate since 2018 and a meaningful decline from the pandemic-era peak of 32.9 per 100,000 in 2022. The improvement represents evidence that targeted federal and state investments in maternal health — including Medicaid postpartum coverage extensions, maternal mortality review committees, and hospital-level quality improvement programs — are producing measurable results.

The 2022 peak was driven by a confluence of factors: COVID-19 complications in pregnant patients, deferred prenatal care, and a preexisting crisis in maternal health infrastructure disproportionately affecting Black and rural women. The decline to 17.9 reflects two years of sustained policy intervention. Forty-six states have now extended Medicaid postpartum coverage from 60 days to 12 months, ensuring new mothers maintain access to care during the highest-risk period. Hospital systems implemented standardized hemorrhage and preeclampsia protocols based on Alliance for Innovation on Maternal Health (AIM) bundles. Telehealth expansion improved prenatal access in underserved areas.

The progress, while significant, still leaves the U.S. well behind peer nations. The UK's rate is approximately 10 per 100,000; Scandinavia's is below 5. The racial disparity remains stark: Black maternal mortality is roughly three times the white rate, even after the overall decline. For healthcare organizations, the data validates the approach of targeted, protocol-driven quality improvement supported by coverage expansion. The lesson applies beyond obstetrics: invest in standardized protocols, extend coverage windows, and deploy telehealth for access — and outcomes improve. The maternal mortality decline is a proof point for what works in population health.

What to watch: Whether the Medicaid work requirements and coverage contractions reverse these gains — maternal mortality improvements are directly tied to coverage access that is now under political threat.